Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Mineralys Raises $192m In Year’s Biggest IPO So Far

Despite Market’s Embrace, Restructuring Continues

Feb 10 2023

• By Mandy Jackson

Finance Watch Public Company — • Source: Alamy

Related Content

Finance Watch: Kronos Bio IPO Raises $250m To Fund Novel Cancer Drugs

Oct 11 2020

Deal Watch: Merck & Co. Looks To Advance NASH Ambitions With Aligos

Dec 08 2020

Collegium, BioDelivery To Combine Pain Portfolios In Proposed Merger

Feb 14 2022

Oramed Failure Highlights Insurmountable Challenge Of Oral Insulin Delivery

Jan 13 2023

Financing Available For Some, But Not All Biopharma Companies In 2023

Jan 18 2023

Mineralys Looks To Path Ahead For MLS-101 In Hypertension

Nov 16 2022

Finance Watch: Resilience Raises $625m, Bringing New Cash To $1.2bn

Jun 08 2022

Related Companies

Mineralys Therapeutics, Inc.

Structure Therapeutics, Inc.

Collegium Pharmaceutical, Inc.

BioDelivery Sciences International, Inc.

Spruce Biosciences, Inc.

aTyr Pharma, Inc.

Climb Bio, Inc.

Oramed Pharmaceuticals Inc.

Aligos Therapeutics, Inc.

Merck & Co., Inc.

Magenta Therapeutics, Inc.

Additional Topics

Financing Restructuring Business Strategies Growth Commercial Finance Watch BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.